Opioid Overdose
Cluster Number:
Wiki Number: PW143
Diagnosis: Opioid Overdose
US Patients: 110,000 deaths + more with permanent brain damage (2017)
World Patients: 500,000 deaths, world wide
Sex Ratio:
Age Onset:
Brain Area: inadequate oxygen in the brain in the medulla and pons can lead to death or brain damage
Symptoms: Inability to breathe or decreased consciousness can kill.
Progression:
Causes:
Medications: Naloxone has reversed more than 25,000 overdoses by 2014.
Therapies: Used as directed, Lohr’s DVD and Download, “Calming My Pain!” avoidusing opioids for post-surgical or other causes of pain.
Youtube Video:
A Real Life Opioid Overdose
Youtube Video: Addressing Opioid Overdose in the Workplace
Amazon or Library Book: Opioids, Opiates, and Overdose
Click the book to link or buy from Amazon.
Support Group: samhsa.gov; 800-662-4357
(U.S. Substance Abuse Mental Health Services Administration)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Microphysiological system to address the opioid crisis: A novel multi-organ model of acute opioid overdose and recoveryby Aakash Patel on January 22, 2025
Opioids have been the primary method used to manage pain for hundreds of years, however the increasing prescription rate of these drugs in the modern world has led to a public health crisis of overdose related deaths. Naloxone is the current standard treatment for opioid overdose rescue, but it has not been fully investigated for potential off-target toxicity effects. The current methods for pharmaceutical development do not correlate well with pre-clinical animal studies compared to clinical...
- Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional Surveyby Elissa Ong on January 21, 2025
The World Health Organisation (WHO) has set goals to eliminate hepatitis C (HCV) as a global health threat by 2030. To meet this goal, Australia must increase testing and diagnosis, including expanding access to care through community pharmacists. This study aims to explore community pharmacists' preparedness to discuss and offer HCV testing and treatment. Australian community pharmacists from four states completed an online anonymous quantitative survey between August and October 2023....
- Retrospective Evaluation of Novel Synthetic Opioids and Xylazine Chronic Intake by Post-Mortem Hair Testingby Marco Ballotari on January 21, 2025
Fentanyl and its derivatives (nonpharmaceutical fentanyl, NPFs) represent the largest group among synthetic opioids. Fentanyl-related deaths and fatalities from tampering with pharmaceutical products have been reported. Furthermore, in the United States, adulterants such as xylazine and other substances, including the nitazenes class of opioids, have been found in an increasing number of unintentional overdose deaths, drug seizures, and reports of use by recreational drug users. Monitoring the...
- Starting a Prehospital Medication for Opioid Use Disorder Programby David C Seaberg on January 20, 2025
CONCLUSIONS: A prehospital MOUD program can be established to expand access to early treatment and continuity of care for patients with OUD. The program was well-received by the local city fire department and QRT. There is a plan to expand the prehospital MOUD program to other local fire departments with QRTs.